E-LIB Suche - Ergebnisse für: Ryder, W David

1

A Phase II randomized controlled trial of oral prednisolone..:

Griffiths-Jones, Deborah J ; Garcia, Yvonne Sylvestre ; Ryder, W David...
Rheumatology. 62 (2023) 9 - p. 3133-3138 , 2023

Link: https://doi.org/10.1093/..

2

A randomised, pragmatic clinical trial of ACUpuncture plus ..:

Stringer, Jacqui ; Ryder, W. David ; Mackereth, Peter A...
European Journal of Oncology Nursing. 60 (2022) - p. 102171 , 2022

Link: https://doi.org/10.1016/..

3

Second-line FOLFOX chemotherapy versus active symptom contr..:

Lamarca, Angela ; Palmer, Daniel H ; Wasan, Harpreet Singh...
The Lancet Oncology. 22 (2021) 5 - p. 690-701 , 2021

Link: https://doi.org/10.1016/..

4

Isotoxic Intensity Modulated Radiation Therapy in Stage III..:

Haslett, Kate ; Bayman, Neil ; Franks, Kevin...
International Journal of Radiation Oncology*Biology*Physics. 109 (2021) 5 - p. 1341-1348 , 2021

Link: https://doi.org/10.1016/..

5

Clinical trial protocol: PRednisolone in early diffuse cuta..:

Herrick, Ariane L ; Griffiths-Jones, Deborah J ; Ryder, W David..
Journal of Scleroderma and Related Disorders. 6 (2020) 2 - p. 146-153 , 2020

Link: https://doi.org/10.1177/..

6

An integrated genomic approach identifies that the PI3K/AKT..:

Smit, Linda ; Berns, Katrien ; Spence, Katherine...
Oncotarget. 7 (2015) 3 - p. 2596-2610 , 2015

Link: https://doi.org/10.18632..

7

The Effectiveness of Acupressure for the Control and Manage..:

Molassiotis, Alexander ; Russell, Wanda ; Hughes, John...
Journal of Pain and Symptom Management. 47 (2014) 1 - p. 12-25 , 2014

Link: https://doi.org/10.1016/..

8

A double-blind, placebo-controlled, randomised trial of act..:

Bardy, Joy ; Molassiotis, Alex ; Ryder, W. David...
British Journal of Oral and Maxillofacial Surgery. 50 (2012) 3 - p. 221-226 , 2012

Link: https://doi.org/10.1016/..

9

The use of thyroid function tests in the diagnosis of hypop..:

Jostel, Andreas ; Ryder, W. David J. ; Shalet, Stephen M.
Clinical Endocrinology. 71 (2009) 4 - p. 529-534 , 2009

Link: https://doi.org/10.1111/..

10

Tumor Epression of Major Vault Protein is an Adverse Progno..:

Silva, Priyamal ; West, Catharine M. ; Slevin, Nick...
International Journal of Radiation Oncology*Biology*Physics. 69 (2007) 1 - p. 133-140 , 2007

Link: https://doi.org/10.1016/..

11

Radiotherapy for muscle-invasive carcinoma of the bladder: ..:

Cowan, Richard A ; McBain, Catherine A ; Ryder, W.David J...
International Journal of Radiation Oncology*Biology*Physics. 59 (2004) 1 - p. 197-207 , 2004

Link: https://doi.org/10.1016/..

12

Paradoxical elevations in serum IGF‐II and IGF binding prot..:

Renehan, Andrew G. ; Toogood, Andrew A. ; Ryder, W. David...
Clinical Endocrinology. 55 (2001) 4 - p. 469-475 , 2001

Link: https://doi.org/10.1046/..

13

A Phase II randomised controlled trial of oral prednisolone..:

Griffiths-Jones, Deborah J ; Garcia, Yvonne Sylvestre ; Ryder, W David...
https://discovery.ucl.ac.uk/id/eprint/10163284/1/PRedSS_Rheumatology_Herrick-Denton%20for%20UCL%20upload.pdf. , 2023

Link: https://discovery.ucl.ac..

14

A randomised, pragmatic clinical trial of ACUpuncture plus ..:

Stringer, Jacqui ; Ryder, W. David ; Mackereth, Peter A..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9592667/. , 2022

Link: http://www.ncbi.nlm.nih...

15

Second-line FOLFOX chemotherapy versus active symptom contr..:

Lamarca, Angela ; Palmer, Daniel H ; Wasan, Harpreet Singh...
Lamarca , A , Palmer , D H , Wasan , H S , Ross , P J , Ma , Y T , Arora , A , Falk , S , Gillmore , R , Wadsley , J , Patel , K , Anthoney , A , Maraveyas , A , Iveson , T , Waters , J S , Hobbs , C , Barber , S , Ryder , W D , Ramage , J , Davies , L M , Bridgewater , J A & Valle , J W 2021 , ' Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial ' , The Lancet Oncology , vol. 22 , no. 5 , pp. 690-701 . https://doi.org/10.1016/S1470-2045(21)00027-9. , 2021

Link: https://research.manches..